China Resources Medical Holdings CoCMHDF 88 Peter Lynch Fair Value is $0.93 as of Jul. 11, 2026, which is 107% above its 10-year median of 0.45. GuruFocus rates CMHDF with a GF Score™ of 88/100 and a GF Value™ of $0.94. The stock has 5 warning signs investors should review. Among 170 Healthcare Providers & Services companies, China Resources Medical Holdings Co ranks better than 95.88% on this metric.
Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.
The historical rank and industry rank for China Resources Medical Holdings Co's Peter Lynch Fair Value or its related term are showing as below:
CMHDF'
s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.34 Med: 0.45 Max: 1.05
Current: 0.34
During the past 13 years, the highest Price to Peter Lynch Fair Value Ratio of China Resources Medical Holdings Co was 1.05. The lowest was 0.34. And the median was 0.45.
CMHDF's Price-to-Peter-Lynch-Fair-Value is ranked better than 95.88% of 170
companies
in the Healthcare Providers & Services industry
Industry Median: 1.185
vs CMHDF: 0.34
Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.
China Resources Medical Holdings Co (OTCPK:CMHDF) Peter Lynch Fair Value Explanation
Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.
Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.
Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 23.79 instead of 15 in this case.
China Resources Medical Holdings Co's Price to Peter Lynch Fair Value Ratio for today is calculated as
Price to Peter Lynch Fair Value
=
Share Price
/
Peter Lynch Fair Value
=
0.58
/
0.93
=
0.63
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Resources Medical Holdings Co Peter Lynch Fair Value Related Terms
China Resources Medical Holdings Co Peter Lynch Fair Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Resources Medical Holdings Co Peter Lynch Fair Value Chart
CMHDF vs HCA, THC, DVA: Peter Lynch Fair Value Comparison
For the Medical Care Facilities subindustry, China Resources Medical Holdings Co's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Resources Medical Holdings Co Price-to-Peter-Lynch-Fair-Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, China Resources Medical Holdings Co's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:
* The bar in red indicates where China Resources Medical Holdings Co's Price-to-Peter-Lynch-Fair-Value falls into.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. China Resources Medical Holdings Co's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was $0.04.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.
If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.
If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.
Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.
China Resources Medical Holdings Co (CMHDF) has a Peter Lynch Fair Value of $0.93 as of Jul. 11, 2026. Peter Lynch Fair Value is the stock value based on a company's current earnings and five-year earnings growth, assuming a PEG of one. View historical data on China Resources Medical Holdings Co and its competitors. This is 107% above median its historical median of 0.45. Over the past decade, China Resources Medical Holdings Co's Peter Lynch Fair Value has ranged from 0.34 to 1.05. According to the industry distribution chart, China Resources Medical Holdings Co ranks #7 out of 170 companies in the Healthcare Providers & Services industry, placing it in the top 4.1%.
Is China Resources Medical Holdings Co's Peter Lynch Fair Value too high?
China Resources Medical Holdings Co's current Peter Lynch Fair Value of $0.93 is 107% above median its 10-year median of 0.45. Over the past 10 years, this metric has ranged from a low of 0.34 to a high of 1.05. The Healthcare Providers & Services industry median Peter Lynch Fair Value is 1.19. China Resources Medical Holdings Co's value of $0.93 is 21.5% below this industry median. Based on the distribution chart, China Resources Medical Holdings Co ranks #7 out of 170 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, China Resources Medical Holdings Co has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does China Resources Medical Holdings Co's Peter Lynch Fair Value compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, China Resources Medical Holdings Co ranks #7 out of 170 companies for Peter Lynch Fair Value. This places China Resources Medical Holdings Co in the top 4% of its industry — outperforming the majority of peers. The industry median Peter Lynch Fair Value is 1.19. China Resources Medical Holdings Co's value of $0.93 is 21.5% below this benchmark. Historically, China Resources Medical Holdings Co's own Peter Lynch Fair Value has ranged from 0.34 to 1.05 over the past decade. While the company's 10-year median is 0.45 vs. the industry median of 1.19, China Resources Medical Holdings Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Peter Lynch Fair Value for a Healthcare Providers & Services company?
The median Peter Lynch Fair Value among Healthcare Providers & Services companies is 1.19, based on 170 companies in the industry. Companies in the top quartile (top 25%) have a Peter Lynch Fair Value significantly above this median, while those in the bottom quartile fall well below. However, Peter Lynch Fair Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Resources Medical Holdings Co's current Peter Lynch Fair Value of $0.93 is 21.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Peter Lynch Fair Value mean?
A high Peter Lynch Fair Value can signal that a stock is expensive relative to its fundamentals. Peter Lynch Fair Value is the stock value based on a company's current earnings and five-year earnings growth, assuming a PEG of one. View historical data on China Resources Medical Holdings Co and its competitors. For the Healthcare Providers & Services industry, the median Peter Lynch Fair Value is 1.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Resources Medical Holdings Co's current Peter Lynch Fair Value is $0.93, which is 107% above median its own 10-year median of 0.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Resources Medical Holdings Co stock overvalued right now?
China Resources Medical Holdings Co (CMHDF) has a current Peter Lynch Fair Value of $0.93. The stock's GF Value™ is $0.94, compared to a current price of $0.58 — trading 38.3% below its estimated fair value. The current Peter Lynch Fair Value is $0.93, which is 107% above median its 10-year median of 0.45 and 21.5% below the Healthcare Providers & Services industry median of 1.19. China Resources Medical Holdings Co's overall GF Score™ is 88/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Peter Lynch Fair Value calculated?
Peter Lynch Fair Value is calculated from a company's financial statements. For China Resources Medical Holdings Co (CMHDF), the current Peter Lynch Fair Value is $0.93 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Resources Medical Holdings Co (CMHDF) Overvalued in 2026?
Based on GuruFocus' analysis, China Resources Medical Holdings Co stock appears to be undervalued.
The current stock price of $0.58 is trading 38.3% below its estimated GF Value™ of $0.94.
Key valuation signals for CMHDF:
Peter Lynch Fair Value: $0.93 (107% above median its 10-year median of 0.45)
GF Value™: $0.94 vs. price of $0.58 (38.3% below fair value)
Industry Position: 21.5% below the Healthcare Providers & Services median (#7 of 170)
No single metric tells the full story. See the CMHDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Resources Medical Holdings Co Business Description
China Resources Medical Holdings Co Ltd is engaged in the provision of general healthcare services; provision of hospital management services, sale of pharmaceuticals, medical devices, and medical consumables, and provision of other services in the Chinese Mainland. The group has two operating segments: Hospital Business and Other Business. The Hospital Business segment includes outpatient business and inpatient business corresponding to self-owned hospitals. The Other business segment includes operation management services, supply chain services, and other ancillary services provided to participating hospitals and IOT/OT hospitals. It generates the majority of its revenue from the Hospital Business segment.
88GF Score
Get the complete analysis for CMHDF
Peter Lynch Fair Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CMHDF has been successfully added to your 
